Oncology

Analytic approaches to clinical validation of results from preclinical models of glioblastoma: a systematic review
Beth Fitt, Grace Loy, Edward Christopher, Paul M Brennan, Michael TC Poon

medRxiv 2021.09.04.21263119; doi: https://doi.org/10.1101/2021.09.04.21263119

Add to Selected Citations
Disparities in accessibility to oncology care centers in France
Eric Daoud, Anne-Sophie Hamy-Petit, Elise Dumas, Lidia Delrieu, Beatriz Grandal Rejo, Christine Le Bihan-Benjamin, Sophie Houzard, Philippe-Jean Bousquet, Judicaël Hotton, Aude-Marie Savoye, Christelle Jouannaud, Chloé-Agathe Azencott, Marc Lelarge, Fabien Reyal

medRxiv 2021.09.29.21264296; doi: https://doi.org/10.1101/2021.09.29.21264296

Add to Selected Citations
Patient attrition in Molecular Tumour Boards: A Review
Hannah Frost, Donna M. Graham, Louise Carter, Paul O’Regan, Donal Landers, Andre Freitas

medRxiv 2021.10.07.21264241; doi: https://doi.org/10.1101/2021.10.07.21264241

Add to Selected Citations
Identification of atypical circulating tumor cells with prognostic value in metastatic breast cancer patients
Alexia Lopresti, Laurys Boudin, Pascal Finetti, Séverine Garnier, Anaïs Aulas, Maria-Lucia Liberatoscioli, Olivier Cabaud, Arnaud Guille, Alexandre de Nonneville, Quentin Dacosta, Emilie Denicolai, Jihane Pakradouni, Anthony Goncalves, Daniel Birnbaum, Claire Acquaviva, François Bertucci, Emilie Mamessier

medRxiv 2020.09.29.20203653; doi: https://doi.org/10.1101/2020.09.29.20203653

Add to Selected Citations
Covariate clustering: women with breast cancer in southwestern Paraná, Brazil
Neyva M. L. Romeiro, Carolina Panis, Mara C.T. dos Santos, Daniel Rech, Paulo L. Natti, Eliandro R. Cirilo

medRxiv 2021.10.04.21264299; doi: https://doi.org/10.1101/2021.10.04.21264299

Add to Selected Citations
Tumor genomic subtypes orthogonal to mutation burden predict the efficacy of immune checkpoint therapy
Shiro Takamatsu, Junzo Hamanishi, J.B. Brown, Ken Yamaguchi, Koji Yamanoi, Kosuke Murakami, Osamu Gotoh, Seiichi Mori, Masaki Mandai, Noriomi Matsumura

medRxiv 2021.10.03.21264330; doi: https://doi.org/10.1101/2021.10.03.21264330

Add to Selected Citations
“Radiosensitivity Index” (“RSI”) is not fit to be used for dose-adjustments: a pan-cancer analysis
Hitesh B. Mistry

medRxiv 2021.08.13.21262017; doi: https://doi.org/10.1101/2021.08.13.21262017

Add to Selected Citations
Genome-wide cell-free DNA termini in patients with cancer
Norbert Moldovan, Ymke van der Pol, Tom van den Ende, Dries Boers, Sandra Verkuijlen, Aafke Creemers, Jip Ramaker, Trang Vu, Marieke F. Fransen, Michiel Pegtel, Idris Bahce, Hanneke van Laarhoven, Florent Mouliere

medRxiv 2021.09.30.21264176; doi: https://doi.org/10.1101/2021.09.30.21264176

Add to Selected Citations
Evaluating a polygenic hazard score to predict risk of developing metastatic or fatal prostate cancer in the multi-ancestry Million Veteran Program cohort
Meghana S. Pagadala, Julie Lynch, Roshan Karunamuni, Patrick R. Alba, Kyung Min Lee, Fatai Y. Agiri, Tori Anglin, Hannah Carter, J. Michael Gaziano, Guneet Kaur Jasuja, Rishi Deka, Brent S. Rose, Matthew S. Panizzon, Richard L. Hauger, Tyler M. Seibert

medRxiv 2021.09.24.21264093; doi: https://doi.org/10.1101/2021.09.24.21264093

Add to Selected Citations
Incidence Rates of Pediatric Central Nervous Tumors Display No Geographical Variation
Dayton Grogan, Vamsi Reddy, Christopher Banerjee, Jennifer Waller, Theodore Johnson, Ian Heger

medRxiv 2021.09.27.21264205; doi: https://doi.org/10.1101/2021.09.27.21264205

Add to Selected Citations

Oncology

Pages